These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35552009)

  • 1. Oral immunotherapy for children with a high-threshold peanut allergy.
    Haj Yahia S; Machnes-Maayan D; Frizinsky S; Maoz-Segal R; Offenganden I; Kenett RS; Agmon-Levin N; Hovav R; Kidon MI
    Ann Allergy Asthma Immunol; 2022 Sep; 129(3):347-353. PubMed ID: 35552009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peanut oral immunotherapy using an extensively heated and baked novel composition of peanuts.
    Kidon MI; Shavit R; Levy Y; Haj Yahia S; Machnes-Maayan D; Frizinsky S; Maoz-Segal R; Offenganden I; Kenett RS; Nancy AL; Hovav R
    Pediatr Allergy Immunol; 2024 May; 35(5):e14146. PubMed ID: 38783409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probiotic peanut oral immunotherapy versus oral immunotherapy and placebo in children with peanut allergy in Australia (PPOIT-003): a multicentre, randomised, phase 2b trial.
    Loke P; Orsini F; Lozinsky AC; Gold M; O'Sullivan MD; Quinn P; Lloyd M; Ashley SE; Pitkin S; Axelrad C; Metcalfe JR; Su EL; Tey D; Robinson MN; Allen KJ; Prescott SL; Galvin AD; Tang MLK;
    Lancet Child Adolesc Health; 2022 Mar; 6(3):171-184. PubMed ID: 35123664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allergen-specific oral immunotherapy for peanut allergy.
    Nurmatov U; Venderbosch I; Devereux G; Simons FE; Sheikh A
    Cochrane Database Syst Rev; 2012 Sep; (9):CD009014. PubMed ID: 22972130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High Degree of Desensitization After 1 Year of Early-Life Peanut Oral Immunotherapy: Small Children Oral Immunotherapy (SmaChO) Randomized Controlled Trial.
    Uhl C; Klevebro S; Sverremark-Ekström E; Tedner SG; Brandström J; Papageorgiou C; Melén E; Konradsen JR; Nilsson C; Asarnoj A
    J Allergy Clin Immunol Pract; 2024 May; 12(5):1297-1305. PubMed ID: 38428524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of desensitizing children highly allergic to peanut by high-dose oral immunotherapy.
    Reier-Nilsen T; Michelsen MM; Lødrup Carlsen KC; Carlsen KH; Mowinckel P; Nygaard UC; Namork E; Borres MP; Håland G
    Allergy; 2019 Feb; 74(2):337-348. PubMed ID: 30225844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy, Safety, and Quality of Life in a Multicenter, Randomized, Placebo-Controlled Trial of Low-Dose Peanut Oral Immunotherapy in Children with Peanut Allergy.
    Blumchen K; Trendelenburg V; Ahrens F; Gruebl A; Hamelmann E; Hansen G; Heinzmann A; Nemat K; Holzhauser T; Roeder M; Rosenfeld L; Hartmann O; Niggemann B; Beyer K
    J Allergy Clin Immunol Pract; 2019 Feb; 7(2):479-491.e10. PubMed ID: 30423449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early oral immunotherapy in peanut-allergic preschool children is safe and highly effective.
    Vickery BP; Berglund JP; Burk CM; Fine JP; Kim EH; Kim JI; Keet CA; Kulis M; Orgel KG; Guo R; Steele PH; Virkud YV; Ye P; Wright BL; Wood RA; Burks AW
    J Allergy Clin Immunol; 2017 Jan; 139(1):173-181.e8. PubMed ID: 27522159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose oral immunotherapy for children with anaphylactic peanut allergy in Japan.
    Nagakura KI; Yanagida N; Sato S; Nishino M; Asaumi T; Ogura K; Ebisawa M
    Pediatr Allergy Immunol; 2018 Aug; 29(5):512-518. PubMed ID: 29603410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral peanut immunotherapy in children with peanut anaphylaxis.
    Blumchen K; Ulbricht H; Staden U; Dobberstein K; Beschorner J; de Oliveira LC; Shreffler WG; Sampson HA; Niggemann B; Wahn U; Beyer K
    J Allergy Clin Immunol; 2010 Jul; 126(1):83-91.e1. PubMed ID: 20542324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peanut Oral Immunotherapy With or Without H
    Chu DK; Freitag T; Marrin A; Walker TD; Avilla E; Freitag A; Spill P; Foster GA; Thabane L; Jordana M; Waserman S
    J Allergy Clin Immunol Pract; 2022 Sep; 10(9):2386-2394. PubMed ID: 35643280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parent and child perception of quality of life in a randomized controlled peanut oral immunotherapy trial.
    Reier-Nilsen T; Carlsen KCL; Michelsen MM; Drottning S; Carlsen KH; Zhang C; Borres MP; Håland G
    Pediatr Allergy Immunol; 2019 Sep; 30(6):638-645. PubMed ID: 31013372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral immunotherapy using boiled peanuts for treating peanut allergy: An open-label, single-arm trial.
    Grzeskowiak LE; Tao B; Aliakbari K; Chegeni N; Morris S; Chataway T
    Clin Exp Allergy; 2023 Mar; 53(3):327-336. PubMed ID: 36628520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring Ara h 1, 2 and 3-sIgE and sIgG4 antibodies in peanut allergic children receiving oral rush immunotherapy.
    Nozawa A; Okamoto Y; Movérare R; Borres MP; Kurihara K
    Pediatr Allergy Immunol; 2014 Jun; 25(4):323-8. PubMed ID: 24953293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of high-dose peanut oral immunotherapy with factors predicting outcome.
    Anagnostou K; Clark A; King Y; Islam S; Deighton J; Ewan P
    Clin Exp Allergy; 2011 Sep; 41(9):1273-81. PubMed ID: 21414048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial: a critical appraisal.
    Marrs T; Flohr C; Perkin MR
    Br J Dermatol; 2015 Nov; 173(5):1125-9. PubMed ID: 26769642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study protocol of a multicentre, randomised, controlled trial evaluating the effectiveness of probiotic and peanut oral immunotherapy (PPOIT) in inducing desensitisation or tolerance in children with peanut allergy compared with oral immunotherapy (OIT) alone and with placebo (the PPOIT-003 study).
    Chebar Lozinsky A; Loke P; Orsini F; O'Sullivan M; L Prescott S; Gold MS; Quinn P; DunnGalvin A; Lk Tang M;
    BMJ Open; 2020 Sep; 10(9):e035871. PubMed ID: 32912942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AR101 Oral Immunotherapy for Peanut Allergy.
    ; Vickery BP; Vereda A; Casale TB; Beyer K; du Toit G; Hourihane JO; Jones SM; Shreffler WG; Marcantonio A; Zawadzki R; Sher L; Carr WW; Fineman S; Greos L; Rachid R; Ibáñez MD; Tilles S; Assa’ad AH; Nilsson C; Rupp N; Welch MJ; Sussman G; Chinthrajah S; Blumchen K; Sher E; Spergel JM; Leickly FE; Zielen S; Wang J; Sanders GM; Wood RA; Cheema A; Bindslev-Jensen C; Leonard S; Kachru R; Johnston DT; Hampel FC; Kim EH; Anagnostou A; Pongracic JA; Ben-Shoshan M; Sharma HP; Stillerman A; Windom HH; Yang WH; Muraro A; Zubeldia JM; Sharma V; Dorsey MJ; Chong HJ; Ohayon J; Bird JA; Carr TF; Siri D; Fernández-Rivas M; Jeong DK; Fleischer DM; Lieberman JA; Dubois AEJ; Tsoumani M; Ciaccio CE; Portnoy JM; Mansfield LE; Fritz SB; Lanser BJ; Matz J; Oude Elberink HNG; Varshney P; Dilly SG; Adelman DC; Burks AW
    N Engl J Med; 2018 Nov; 379(21):1991-2001. PubMed ID: 30449234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful oral tolerance induction in severe peanut allergy.
    Clark AT; Islam S; King Y; Deighton J; Anagnostou K; Ewan PW
    Allergy; 2009 Aug; 64(8):1218-20. PubMed ID: 19226304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early Peanut Immunotherapy in Children (EPIC) trial: protocol for a pragmatic randomised controlled trial of peanut oral immunotherapy in children under 5 years of age.
    O'Sullivan MD; Bear N; Metcalfe J
    BMJ Paediatr Open; 2023 Nov; 7(1):. PubMed ID: 37963680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.